Author Interviews, Cancer Research, ENT, JAMA, Surgical Research / 06.11.2018
Treatment Delays Linked To High Mortality for Head and Neck Cancer
MedicalResearch.com Interview with:
[caption id="attachment_45744" align="alignleft" width="200"] Dr. Graboyes[/caption]
Dr. Evan M. Graboyes MD
Otolaryngologist: Head and Neck Surgeon
Medical University of South Carolina
MedicalResearch.com: What is the background for this study?
Response: Unfortunately, there is no screening test for head and neck cancer like there is for colorectal, prostate, breast, lung, or cervical cancers. As a result, two-thirds of patients with head and neck cancer (HNC) present with loco-regionally advanced disease, making other aspects of timely treatment that much more critically important. We therefore sought to understand the association between treatment delay at different points along the cancer care continuum and oncologic outcomes for patients with head and neck cancer.
Dr. Graboyes[/caption]
Dr. Evan M. Graboyes MD
Otolaryngologist: Head and Neck Surgeon
Medical University of South Carolina
MedicalResearch.com: What is the background for this study?
Response: Unfortunately, there is no screening test for head and neck cancer like there is for colorectal, prostate, breast, lung, or cervical cancers. As a result, two-thirds of patients with head and neck cancer (HNC) present with loco-regionally advanced disease, making other aspects of timely treatment that much more critically important. We therefore sought to understand the association between treatment delay at different points along the cancer care continuum and oncologic outcomes for patients with head and neck cancer.